FRAZER, Pa., May 16 /PRNewswire-FirstCall/ -- Cephalon, Inc. announced that John E. Osborn, Executive Vice President and General Counsel, has been nominated by President George W. Bush to serve as a member of the United States Advisory Commission on Public Diplomacy. The Commission is a seven member bipartisan panel established by the Congress in 1948 to provide advice and oversight of all U.S. Government activities intended to understand, inform, and influence foreign publics. The nomination is subject to confirmation by the United States Senate. The White House announcement concerning the nomination can be found at http://www.whitehouse.gov/news/releases/2007/05/20070510-11.html .
Osborn will continue to manage all legal, government and public affairs matters for Cephalon.
From 1989 to 1992, Osborn served as Special Assistant to the Legal Adviser with the U.S. Department of State during the George H.W. Bush Administration, and prior to that worked in the offices of former U.S. Representative Jim Leach of Iowa and the late U.S. Senator John Heinz of Pennsylvania. Osborn also worked on several presidential campaigns, beginning with the 1980 Bush campaign. In 2004, Osborn was appointed by then U.S. Secretary of State Colin L. Powell to serve as one of five national members of the Board of Governors of the East-West Center, an education and research organization based in Honolulu, Hawaii that is focused on the Asia Pacific region.
Osborn has held a visiting appointment in politics at Princeton University, where he was a research fellow at the University's Bobst Center for Peace and Justice, and has been an Eisenhower Fellow to Ireland and Northern Ireland, and a visiting scholar in East European Studies with the Woodrow Wilson International Center for Scholars in Washington. He is a member of the Council on Foreign Relations and the American Law Institute, and a fellow of the American Bar Foundation.
The U.S. Advisory Commission on Public Diplomacy
The Commission, now in its 59th year, was reauthorized in May 2007 pursuant to Public Law 110-21. It is responsible for assessing public diplomacy policies and programs of the U.S. State Department, American missions abroad, and other agencies. Advisory Commission responsibilities extend to international exchanges, U.S. Government international information programs, and publicly funded non-governmental organizations. The Commission reports its findings and recommendations to the President, the Congress, the Secretary of State, and the American people. For more on the Commission, please visit http://www.state.gov/r/adcompd .
Cephalon, Inc.
Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. A first time member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. Cephalon's European headquarters are located in Maisons-Alfort, France. The company's proprietary products in the United States include: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet) [C-II], TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The Company also markets numerous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.
Cephalon, Inc.CONTACT: Sheryl Williams of Cephalon, Inc., +1-610-738-6493,swilliam@cephalon.com
Company News On-Call: http://www.prnewswire.com/comp/134563.html /
